These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 11179722)

  • 21. 1α,25(OH)₂-vitamin D and a nongenomic vitamin D analogue inhibit ultraviolet radiation-induced skin carcinogenesis.
    Dixon KM; Norman AW; Sequeira VB; Mohan R; Rybchyn MS; Reeve VE; Halliday GM; Mason RS
    Cancer Prev Res (Phila); 2011 Sep; 4(9):1485-94. PubMed ID: 21733837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dual 1,25-dihydroxyvitamin D3 signal response pathways in osteoblasts: cross-talk between genomic and membrane-initiated pathways.
    Farach-Carson MC; Ridall AL
    Am J Kidney Dis; 1998 Apr; 31(4):729-42. PubMed ID: 9531195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of renal vitamin D receptor is an important determinant of 1alpha,25-dihydroxyvitamin D(3) levels in vivo.
    Beckman MJ; DeLuca HF
    Arch Biochem Biophys; 2002 May; 401(1):44-52. PubMed ID: 12054486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Steroid hormone action in musculoskeletal cells involves membrane receptor and nuclear receptor mechanisms.
    Boyan BD; Dean DD; Sylvia VL; Schwartz Z
    Connect Tissue Res; 2003; 44 Suppl 1():130-5. PubMed ID: 12952186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 1alpha,25(OH)2-Vitamin D3 stimulation of secretion via chloride channel activation in Sertoli cells.
    Menegaz D; Barrientos-Duran A; Kline A; Silva FR; Norman AW; Mizwicki MT; Zanello LP
    J Steroid Biochem Mol Biol; 2010 Apr; 119(3-5):127-34. PubMed ID: 20156558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of an alternative ligand-binding pocket in the nuclear vitamin D receptor and its functional importance in 1alpha,25(OH)2-vitamin D3 signaling.
    Mizwicki MT; Keidel D; Bula CM; Bishop JE; Zanello LP; Wurtz JM; Moras D; Norman AW
    Proc Natl Acad Sci U S A; 2004 Aug; 101(35):12876-81. PubMed ID: 15326291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MAPK inhibition by 1alpha,25(OH)2-Vitamin D3 in breast cancer cells. Evidence on the participation of the VDR and Src.
    Rossi AM; Capiati DA; Picotto G; Benassati S; Boland RL
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):287-90. PubMed ID: 15225787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nongenomic and genomic effects of 1α,25(OH)2 vitamin D3 in rat testis.
    Zanatta L; Zamoner A; Zanatta AP; Bouraïma-Lelong H; Delalande C; Bois C; Carreau S; Silva FR
    Life Sci; 2011 Oct; 89(15-16):515-23. PubMed ID: 21565203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health.
    Norman AW
    Am J Clin Nutr; 2008 Aug; 88(2):491S-499S. PubMed ID: 18689389
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of serum-stimulated mitogen activated protein kinase by 1alpha,25(OH)2-vitamin D3 in MCF-7 breast cancer cells.
    Capiati DA; Rossi AM; Picotto G; Benassati S; Boland RL
    J Cell Biochem; 2004 Oct; 93(2):384-97. PubMed ID: 15368364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Response element and coactivator-mediated conformational change of the vitamin D(3) receptor permits sensitive interaction with agonists.
    Herdick M; Bury Y; Quack M; Uskokovic MR; Polly P; Carlberg C
    Mol Pharmacol; 2000 Jun; 57(6):1206-17. PubMed ID: 10825392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytochromes P450 are essential players in the vitamin D signaling system.
    Schuster I
    Biochim Biophys Acta; 2011 Jan; 1814(1):186-99. PubMed ID: 20619365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for Vitamin D Receptor Expression and Direct Effects of 1α,25(OH)2D3 in Human Skeletal Muscle Precursor Cells.
    Olsson K; Saini A; Strömberg A; Alam S; Lilja M; Rullman E; Gustafsson T
    Endocrinology; 2016 Jan; 157(1):98-111. PubMed ID: 26469137
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural Studies of Vitamin D Nuclear Receptor Ligand-Binding Properties.
    Belorusova AY; Rochel N
    Vitam Horm; 2016; 100():83-116. PubMed ID: 26827949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 25-Dehydro-1alpha-hydroxyvitamin D3-26,23S-lactone antagonizes the nuclear vitamin D receptor by mediating a unique noncovalent conformational change.
    Bula CM; Bishop JE; Ishizuka S; Norman AW
    Mol Endocrinol; 2000 Nov; 14(11):1788-96. PubMed ID: 11075812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms regulating differential activation of membrane-mediated signaling by 1alpha,25(OH)2D3 and 24R,25(OH)2D3.
    Boyan BD; Jennings EG; Wang L; Schwartz Z
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):309-15. PubMed ID: 15225791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanistic studies to evaluate the enhanced antiproliferation of human keratinocytes by 1alpha,25-dihydroxyvitamin D(3)-3-bromoacetate, a covalent modifier of vitamin D receptor, compared to 1alpha,25-dihydroxyvitamin D(3).
    Chen ML; Ray S; Swamy N; Holick MF; Ray R
    Arch Biochem Biophys; 1999 Oct; 370(1):34-44. PubMed ID: 10496974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A-ring analogues of 1, 25-(OH)2D3 with low affinity for the vitamin D receptor modulate chondrocytes via membrane effects that are dependent on cell maturation.
    Greising DM; Schwartz Z; Posner GH; Sylvia VL; Dean DD; Boyan BD
    J Cell Physiol; 1997 Jun; 171(3):357-67. PubMed ID: 9180905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanism of Pdia3-dependent 1α,25-dihydroxy vitamin D3 signaling in musculoskeletal cells.
    Boyan BD; Chen J; Schwartz Z
    Steroids; 2012 Aug; 77(10):892-6. PubMed ID: 22569272
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse.
    Masuda S; Byford V; Arabian A; Sakai Y; Demay MB; St-Arnaud R; Jones G
    Endocrinology; 2005 Feb; 146(2):825-34. PubMed ID: 15498883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.